UNITED STATES
SECURITIES AND EXCHANGE COMMISSION  
Washington, D.C. 20549  
 
FORM 8-K  
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
 
Securities Exchange Act of 1934  
 
Date of report (Date of earliest event reported): June 23, 2010 (June 18, 2010)
 
CardioGenics Holdings Inc.  
(Exact Name of Registrant as Specified in its Charter)

Nevada
000-28761
88-0380546
     
(State or other jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer Identification)
 
6295 Northam Drive, Unit 8, Mississauga, Ontario, L4V 1W8 
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: 905.673.8501
 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
TABLE OF CONTENTS
 
ITEM 5.03 AMENDMENT TO ARTICLES OF INCORPORATION OR BY-LAWS; CHANGE IN FISCAL YEAR
 
 
 
EX-3.1:   CERTIFICATE OF CHANGE OF CARDIOGENICS HOLDINGS INC. EFFECTIVE JUNE 18, 2010
 
EX-99.1:   PRESS RELEASES DATED JUNE 18 , 20 10 AND JUNE 21, 2010

 
 
 
 
Item 5.03 Amendment of Articles of Incorporation or By-Laws; Change in Fiscal Year

On June 18, 2010 CardioGenics Holdings Inc., a Nevada corporation (the “ Company ”), filed with the Nevada Secretary of State’s Office a Certificate of Change, which effected a 1:10 share consolidation of the Company’s outstanding and authorized shares of common stock (the “ Certificate of Change ”),

The foregoing description of the Certificate of Change does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Change filed as Exhibit 3.1 hereto, which is incorporated herein by reference. Press releases regarding the filing of the Certificate of Change and the status of the share consolidation are also filed as Exhibit 99.1 hereto.


Item 9.01 Financial Statements and Exhibits.

Index to Exhibits

3.1
 
Certificate of Change of CardioGenics Holdings Inc. Effective June 18, 2010
     
99.1
 
Press Releases dated June 18, 2010 and June 21, 2010
 
 
 
 
 
SIGNATURE
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CARDIOGENICS HOLDINGS INC.
 
     
 
By:
/s/ Yahia Gawad
 
   
Name:
Yahia Gawad
 
   
Title:
Chief Exec utive Officer
 


Dat ed: June 23 , 20 10

 
 
 
 
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more CardioGenics (CE) Charts.
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more CardioGenics (CE) Charts.